Showing results (71-80 of 239) with videos related to
Sort By:
Pageof 24
Kidney International. Supplement|May 2, 2002
Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patientsGeorge M Nassar, Steven Fishbane, Juan Carlos AyusAmerican Journal of Nephrology|January 30, 2007
Risk for acute renal failure in patients hospitalized for decompensated congestive heart failureHarini Chittineni, Nobuyuki Miyawaki, Sailaja Gulipelli, et al.Clinical Kidney Journal|May 8, 2023
Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefinedSteven Fishbane, Deepa A Malieckal, Ji H NgThe Annals of Pharmacotherapy|October 15, 2009
Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacistsShaffeeulah Bacchus, Neeta O'Mara, Harold Manley, et al.Seminars in Nephrology|May 29, 2016
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing HemodialysisHitesh H Shah, Azzour D Hazzan, Steven FishbaneCurrent Opinion in Nephrology and Hypertension|June 8, 2015
Novel iron-based phosphate binders in patients with chronic kidney diseaseHitesh H Shah, Azzour D Hazzan, Steven FishbaneClinical Journal of the American Society of Nephrology : CJASN|January 24, 2012
Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatmentAlan S Kliger, Steven Fishbane, Fredric O FinkelsteinKidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.Advances in Chronic Kidney Disease|January 18, 2006
Anemia in the kidney-transplant patientHeidi Joist, Daniel C Brennan, Daniel W CoyneKidney International Supplements|January 25, 2019
New options for the anemia of chronic kidney diseaseDaniel W Coyne, David Goldsmith, Iain C MacdougallPageof 24